Journal of Oncology / 2012 / Article / Fig 2

Research Article

Lack of Efficacy of Combined Antiangiogenic Therapies in Xenografted Human Melanoma

Figure 2

Quantification of hypoxic and necrotic areas in tumor xenografts treated with TekdeltaFc and LDM CTX. (a) Representative low (5x, left) and high (20x, right) magnification images of hypoxia immunostaining for Hypoxyprobe adducts and tissue necrosis in tumor sections. Dark brown areas are hypoxic (arrow), light brown areas are viable tumor (arrowhead), and areas lacking brown reaction product and containing degraded nuclei are necrotic tissue (asterisk). (b) Quantification of the mean percent viable tissue, hypoxia, necrosis, or hypoxia and necrosis in each treatment group, showing significant differences in proportions of necrotic, and necrotic plus hypoxic areas in LDM-CTX-treated tumors compared to control and combination (* 𝑃 < 0 . 0 5 ).
794172.fig.002a
(a)
794172.fig.002b
(b)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.